Blood cancers, Myeloma
Results
Other
This study looked at how often people being treated with lenalidomide and dexamethasone for myeloma have a very low number of white blood cells (neutropenia).
Recruitment start: 17 January 2011
Recruitment end: 5 July 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Williams
Amgen
Last reviewed: 26 January 2018
CRUK internal database number: 8194